Relative vaccine effectiveness of adjuvanted trivalent influenza vaccine compared to egg-based trivalent high dose and other egg-based vaccines

Схожие документы

• Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019–20 Influenza Season—A Retrospective Cohort Analysis
  по: Myron J. Levin, и др.
  Опубликовано: (2021-10-01)
• A clinical and economic assessment of adjuvanted trivalent versus standard egg-derived quadrivalent influenza vaccines among older adults in the United States during the 2018-19 and 2019-20 influenza seasons
  по: Myron J. Levin, и др.
  Опубликовано: (2024-12-01)
• Clinical and Economic Outcomes Associated with Cell-Based Quadrivalent Influenza Vaccine vs. Standard-Dose Egg-Based Quadrivalent Influenza Vaccines during the 2018–19 Influenza Season in the United States
  по: Girishanthy Krishnarajah, и др.
  Опубликовано: (2021-01-01)
• Relative vaccine effectiveness of MF59-adjuvanted vs high-dose trivalent inactivated influenza vaccines for prevention of test-confirmed influenza hospitalizations during the 2017–2020 influenza seasons
  по: Ian McGovern, и др.
  Опубликовано: (2024-09-01)
• Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine over Three Consecutive Influenza Seasons in the United States
  по: Constantina Boikos, и др.
  Опубликовано: (2022-09-01)